The Contributions of Human Mini-Intestines to the Study of Intestinal Physiology and Pathophysiology

Annual Review of Physiology

Volumn 79, Issue , 2017, Pages 291-312

  Yu, Huimin ^a   Hasan, Nesrin M ^a   In, Julie G ^a   Estes, Mary K ^b   Kovbasnjuk, Olga ^a   Zachos, Nicholas C ^a   Donowitz, Mark ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Enteroids; Host pathogen; Intestinal physiology; Organoids; Transport

Indexed keywords

TETRATRICOPEPTIDE REPEAT DOMAIN PROTEIN 7A; TETRATRICOPEPTIDE REPEAT PROTEIN; UNCLASSIFIED DRUG;

CELL DIFFERENTIATION; CELL MATURATION; CELL PLASTICITY; CELL SPECIFICITY; COLORECTAL CARCINOMA; CRYPT CELL; CYSTIC FIBROSIS; CYTOPLASM; DIARRHEA; ENTEROHEMORRHAGIC ESCHERICHIA COLI; GENETIC DISORDER; HOST PATHOGEN INTERACTION; HUMAN; INTESTINE ABSORPTION; INTESTINE VILLUS; PATHOPHYSIOLOGY; PEPTOCLOSTRIDIUM DIFFICILE; PRIORITY JOURNAL; REVIEW; ROTAVIRUS; SALMONELLA; SMALL INTESTINE DISEASE; ANIMAL; BIOLOGICAL MODEL; ENTEROPATHY; INTESTINE; PATHOLOGY; PHYSIOLOGY; STEM CELL;

ANIMALS; CELL DIFFERENTIATION; HUMANS; INTESTINAL DISEASES; INTESTINES; MODELS, BIOLOGICAL; STEM CELLS;

EID: 85013135273     PISSN: 00664278     EISSN: 15451585     Source Type: Book Series    
DOI: 10.1146/annurev-physiol-021115-105211     Document Type: Review

References (137)

1. Barrett KE. 1993. Positive and negative regulation of chloride secretion in T84 cells. Am. J. Physiol. Cell Physiol. 265:C859-68
2. Oltra-Noguera D, Mangas-Sanjuan V, Centelles-Sangüesa A, Gonzalez-Garcia I, Sanchez-Castaño G, et al. 2015. Variability of permeability estimation from different protocols of subculture and transport experiments in cell monolayers. J. Pharmacol. Toxicol. Methods 71:21-32
3. Davila JC, Rodriguez RJ, Melchert RB, Acosta D Jr. 1998. Predictive value of in vitro model systems in toxicology. Annu. Rev. Pharmacol. Toxicol. 38:63-96
4. Kramer JA, Sagartz JE, Morris DL. 2007. The application of discovery toxicology and pathology towards the design of safer pharmaceutical lead candidates. Nat. Rev. Drug Discov. 6:636-49
5. Olson H, Betton G, Robinson D, Thomas K, Monro A, et al. 2000. Concordance of the toxicity of pharmaceuticals in humans and in animals. Regul. Toxicol. Pharmacol. 32:56-67
6. Cao X, Gibbs ST, Fang L, Miller HA, Landowski CP, et al. 2006. Why is it challenging to predict intestinal drug absorption and oral bioavailability in human using rat model. Pharm. Res. 23:1675-86
7. Giacomini KM, Huang SM, Tweedie DJ, Benet LZ, Brouwer KL, et al. 2010. Membrane transporters in drug development. Nat. Rev. Drug Discov. 9:215-36
8. Hodgson J. 2001. ADMET-turning chemicals into drugs. Nat. Biotechnol. 19:722-26
9. Singh V, Yang J, Chen TE, Zachos NC, Kovbasnjuk O, et al. 2014. Translating molecular physiology of intestinal transport into pharmacologic treatment of diarrhea: stimulation of Na+ absorption. Clin. Gastroenterol. Hepatol. 12:27-31
10. Thiagarajah JR, DonowitzM, Verkman AS. 2015. Secretory diarrhoea: mechanisms and emerging therapies. Nat. Rev. Gastroenterol. Hepatol. 12:446-57
11. Thiagarajah JR, Ko EA, Tradtrantip L, Donowitz M, Verkman AS. Discovery and development of antisecretory drugs for treating diarrheal diseases. Clin. Gastroenterol. Hepatol. 12:204-9
12. Barker N, van Es JH, Kuipers J, Kujala P, van den Born M, et al. 2007. Identification of stem cells in small intestine and colon by marker gene Lgr5. Nature 449:1003-7
13. de Lau W, Barker N, Low TY, Koo B-K, Li VSW, et al. 2011. Lgr5 homologues associate with Wnt receptors and mediate R-spondin signalling. Nature 476:293-97
14. Jaks V, Barker N, Kasper M, van Es JH, Snippert HJ, et al. 2008. Lgr5 marks cycling, yet long-lived, hair follicle stem cells. Nat. Genet. 40:1291-99
15. Jung P, Sato T, Merlos-Suárez A, Barriga FM, Iglesias M, et al. 2011. Isolation and in vitro expansion of human colonic stem cells. Nat. Med. 17:1225-27
16. Li L, CleversH. 2010. Coexistence of quiescent and active adult stem cells in mammals. Science 327:542-45
17. Merlos-Suárez A, Barriga Francisco M, Jung P, Iglesias M, CéspedesMaría V, et al. 2011. The intestinal stem cell signature identifies colorectal cancer stem cells and predicts disease relapse. Cell Stem Cell 8:511-24
18. Sato T, Stange DE, Ferrante M, Vries RGJ, van Es JH, et al. 2011. Long-term expansion of epithelial organoids from human colon, adenoma, adenocarcinoma, and Barrett's epithelium. Gastroenterology 141:1762-72
19. Sato T, van Es JH, Snippert HJ, Stange DE, Vries RG, et al. 2011. Paneth cells constitute the niche for Lgr5 stem cells in intestinal crypts. Nature 469:415-18
20. Sato T, Vries RG, Snippert HJ, van Wetering M, Barker N, et al. 2009. Single Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal niche. Nature 459:262-65
21. Snippert HJ, van der Flier LG, Sato T, Es JH, van den BornM,et al. 2010. Intestinal crypt homeostasis results from neutral competition between symmetrically dividing Lgr5 stem cells. Cell 143:134-44
22. Stelzner M, Helmrath M, Dunn JCY, Henning SJ, Houchen CW, et al. 2012. A nomenclature for intestinal in vitro cultures. Am. J. Physiol. Gastrointest. Liver Physiol. 302:G1359-63
23. Clevers H. 2015. What is an adult stem cell? Science 350:1319-20
24. Koo B-K, Clevers H. 2014. Stem cells marked by the R-spondin receptor LGR5. Gastroenterology 147:289-302
25. Sato T, CleversH. 2013. Growing self-organizingmini-guts from a single intestinal stem cell: mechanism and applications. Science 340:1190-94
26. Date S, Sato T. 2015. Mini-gut organoids: reconstitution of the stem cell niche. Annu. Rev. Cell Dev. Biol. 31:269-89
27. Clevers H. 2013. The intestinal crypt, a prototype stem cell compartment. Cell 154:274-84
28. Dedhia PH, Bertaux-Skeirik N, Zavros Y, Spence JR. 2016. Organoid models of human gastrointestinal development and disease. Gastroenterology 150:1098-112
29. Kovbasnjuk O, Zachos NC, In J, Foulke-Abel J, Ettayebi K, et al. 2013. Human enteroids: preclinical models of non-inflammatory diarrhea. Stem Cell Res. Ther. 4(Suppl. 1):S3
30. Foulke-Abel J, In J, Kovbasnjuk O, Zachos NC, Ettayebi K, et al. 2014. Human enteroids as an ex-vivo model of host-pathogen interactions in the gastrointestinal tract. Exp. Biol. Med. 239:1124-34
31. Zachos NC, Kovbasnjuk O, Foulke-Abel J, In J, Blutt SE, et al. 2016. Human enteroids/colonoids and intestinal organoids functionally recapitulate normal intestinal physiology and pathophysiology. J. Biol. Chem. 291:3759-66
32. Sato T, Vries RG, Snippert HJ, van Wetering M, Barker N, et al. 2009. Single Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal niche. Nature 459:262-65
33. Foulke-Abel J, In J, Yin J, Zachos NC, Kovbasnjuk O, et al. 2016. Human enteroids as a model of upper small intestinal ion transport physiology and pathophysiology. Gastroenterology 150:638-49
34. In J, Foulke-Abel J, Zachos NC, Hansen AM, Kaper JB, et al. 2016. Enterohemorrhagic Escherichia coli reducemucus and intermicrovillar bridges in human stem cell-derived colonoids. Cell. Mol. Gastroenterol. Hepatol. 2:48-62.e3
35. Sato T, Clevers H. 2013. Primary mouse small intestinal epithelial cell cultures. In Epithelial Cell Culture Protocols, ed. HS Randell, LM Fulcher, pp. 319-28. Totowa, NJ: Humana Press. 2nd ed
36. McCracken KW, Howell JC, Wells JM, Spence JR. 2011. Generating human intestinal tissue from pluripotent stem cells in vitro. Nat. Protoc. 6:1920-28
37. Spence JR, Mayhew CN, Rankin SA, Kuhar MF, Vallance JE, et al. 2011. Directed differentiation of human pluripotent stem cells into intestinal tissue in vitro. Nature 470:105-9
38. Wells JM, Spence JR. 2014. How to make an intestine. Development 141:752-60
39. Finkbeiner SR, Hill DR, Altheim CH, Dedhia PH, Taylor MJ, et al. 2015. Transcriptome-wide analysis reveals hallmarks of human intestine development and maturation in vitro and in vivo. Stem Cell Rep. 4:1140-55
40. Watson CL, Mahe MM, Munera J, Howell JC, Sundaram N, et al. 2014. An in vivo model of human small intestine using pluripotent stem cells. Nat. Med. 20:1310-14
41. Wells JM, Spence JR. 2014. How to make an intestine. Development 141:752-60
42. Flier LG, Clevers H. 2009. Stem cells, self-renewal, and differentiation in the intestinal epithelium. Annu. Rev. Physiol. 71:241-60
43. Laabi Y, Metcalf D, Mifsud S, Di Rago L. 2000. Differentiation commitment and regulator-specific granulocyte-macrophage maturation in a novel pro-B murine leukemic cell line. Leukemia 14:1785-95
44. Metcalf D. 1998. Lineage commitment and maturation in hematopoietic cells: the case for extrinsic regulation. Blood 92:345-47
45. Karam SM. 1999. Lineage commitment and maturation of epithelial cells in the gut. Front. Biosci. 4:D286-98
46. Roth KA, Hermiston ML, Gordon JI. 1991. Use of transgenic mice to infer the biological properties of small intestinal stem cells and to examine the lineage relationships of their descendants. PNAS 88:9407-11
47. Shaffiey SA, Jia H, Keane T, Costello C, Wasserman D, et al. 2016. Intestinal stem cell growth and differentiation on a tubular scaffold with evaluation in small and large animals. Regen. Med. 11:45-61
48. Bosse T, Piaseckyj CM, Burghard E, Fialkovich JJ, Rajagopal S, et al. 2006. Gata4 is essential for the maintenance of jejunal-ileal identities in the adult mouse small intestine. Mol. Cell. Biol. 26:9060-70
49. Silberg DG, Swain GP, Suh ER, Traber PG. 2000. Cdx1 and cdx2 expression during intestinal development. Gastroenterology 119:961-71
50. McKie AT, Barrow D, Latunde-Dada GO, Rolfs A, Sager G, et al. 2001. An iron-regulated ferric reductase associated with the absorption of dietary iron. Science 291:1755-59
51. Krasinski SD, Upchurch BH, Irons SJ, June RM, Mishra K, et al. 1997. Rat lactase-phlorizin hydrolase/human growth hormone transgene is expressed on small intestinal villi in transgenic mice. Gastroenterology 113:844-55
52. Dawson PA, Lan T, Rao A. 2009. Bile acid transporters. J. Lipid Res. 50:2340-57
53. Middendorp S, Schneeberger K, Wiegerinck CL, Mokry M, Akkerman RD, et al. 2014. Adult stem cells in the small intestine are intrinsically programmed with their location-specific function. Stem Cells 32:1083-91
54. Amatya VJ, Mawas AS, Kushitani K, Mohi El-Din MM, Takeshima Y. 2016. Differential microRNA expression profiling of mesothelioma and expression analysis of miR-1 and miR-214 in mesothelioma. Int. J. Oncol. 48:1599-607
55. Tetteh PW, Basak O, Farin HF, Wiebrands K, Kretzschmar K, et al. 2016. Replacement of lost Lgr5-positive stem cells through plasticity of their enterocyte-lineage daughters. Cell Stem Cell 18:203-13
56. Farin HF, Jordens I, Mosa MH, Basak O, Korving J, et al. 2016. Visualization of a short-range Wnt gradient in the intestinal stem-cell niche. Nature 530:340-43
57. Valenta T, Degirmenci B, Moor AE, Herr P, Zimmerli D, et al. 2016. Wnt ligands secreted by subepithelial mesenchymal cells are essential for the survival of intestinal stem cells and gut homeostasis. Cell Rep. 15:911-18
58. Spencer AU, Sun X, El-Sawaf M, Haxhija EQ, Brei D, et al. 2006. Enterogenesis in a clinically feasible model of mechanical small-bowel lengthening. Surgery 140:212-20
59. Basson MD, Li GD, Hong F, Han O, Sumpio BE. 1996. Amplitude-dependent modulation of brush border enzymes and proliferation by cyclic strain in human intestinal Caco-2 monolayers. J. Cell. Physiol. 168:476-88
60. Zhang J, Li W, Sanders MA, Sumpio BE, Panja A, Basson MD. 2003. Regulation of the intestinal epithelial response to cyclic strain by extracellular matrix proteins. FASEB J. 17:926-28
61. Kim HJ, Huh D, Hamilton G, Ingber DE. 2012. Human gut-on-A-chip inhabited by microbial flora that experiences intestinal peristalsis-like motions and flow. Lab Chip 12:2165-74
62. Kim HJ, Ingber DE. 2013. Gut-on-A-Chipmicroenvironment induces human intestinal cells to undergo villus differentiation. Integr. Biol. 5:1130-40
63. Kim HJ, Li H, Collins JJ, Ingber DE. 2016. Contributions of microbiome and mechanical deformation to intestinal bacterial overgrowth and inflammation in a human gut-on-A-chip. PNAS 113:E7-15
64. Lin JH, Chiba M, Baillie TA. 1999. Is the role of the small intestine in first-pass metabolism overemphasized? Pharmacol. Rev. 51:135-58
65. Binder HJ. 2009. Mechanisms of diarrhea in inflammatory bowel diseases. Ann. N.Y. Acad. Sci. 1165:285-93
66. Gareau MG, Barrett KE. 2013. Fluid and electrolyte secretion in the inflamed gut: novel targets for treatment of inflammation-induced diarrhea. Curr. Opin. Pharmacol. 13:895-99
67. Keely SJ, Montrose MH, Barrett KE. 2009. Electrolyte secretion and absorption: small intestine and colon. In Textbook of Gastroenterology, ed. T Yamada, pp. 330-67. Chichester, UK:Wiley-Blackwell
68. WelshMJ, Smith PL, FrommM, Frizzell RA. 1982. Crypts are the site of intestinal fluid and electrolyte secretion. Science 218:1219-21
69. Serebro HA, Iber FL, Yardley JH, Hendrix TR. 1969. Inhibition of cholera toxin action in the rabbit by cycloheximide. Gastroenterology 56:506-11
70. Roggin GM, Banwell JG, Yardley JH, Hendrix TR. 1972. Unimpaired response of rabbit jejunum to cholera toxin after selective damage to villus epithelium. Gastroenterology 63:981-89
71. Jakab RL, Collaco AM, Ameen NA. 2011. Physiological relevance of cell-specific distribution patterns of CFTR, NKCC1, NBCe1, and NHE3 along the crypt-villus axis in the intestine. Am. J. Physiol. Gastrointest. Liver Physiol. 300:G82-98
72. De Jonge HR. 1975. The response of small intestinal villous and crypt epithelium to choleratoxin in rat and guinea pig. Evidence against a specific role of the crypt cells in choleragen-induced secretion. Biochim. Biophys. Acta 381:128-43
73. Kockerling A, Fromm M. 1993. Origin of cAMP-dependent Cl-secretion from both crypts and surface epithelia of rat intestine. Am. J. Physiol. 264:C1294-301
74. McNicholas CM, Brown CD, Turnberg LA. 1994. Na-K-Cl cotransport in villus and crypt cells from rat duodenum. Am. J. Physiol. 267:G1004-11
75. Field M. 1976. Regulation of active ion transport in the small intestine. In Acute Diarrhoea in Childhood, Ciba Found. Symp. 42, pp. 109-27. Amsterdam: Elsevier
76. IshiguroH,Namkung W, Yamamoto A, Wang Z, Worrell RT, et al. 2007. Effect of Slc26a6 deletion on apical Cl-/HCO3-exchanger activity and cAMP-stimulated bicarbonate secretion in pancreatic duct. Am. J. Physiol. Gastrointest. Liver Physiol. 292:G447-55
77. Musch MW, Arvans DL, Wu GD, Chang EB. 2009. Functional coupling of the downregulated in adenoma Cl-/base exchanger DRA and the apical Na+/H+ exchangers NHE2 and NHE3. Am. J. Physiol. Gastrointest. Liver Physiol. 296:G202-10
78. Schweinfest CW, Spyropoulos DD, Henderson KW, Kim J-H, Chapman JM, et al. 2006. slc26a3 (dra)-deficient mice display chloride-losing diarrhea, enhanced colonic proliferation, and distinct up-regulation of ion transporters in the colon. J. Biol. Chem. 281:37962-71
79. Shcheynikov N, Wang Y, Park M, Ko SBH, Dorwart M, et al. 2006. Coupling modes and stoichiometry of Cl-/HCO3-exchange by slc26a3 and slc26a6. J. Gen. Physiol. 127:511-24
80. Singh AK, Riederer B, Chen M, Xiao F, Krabbenhöft A, et al. 2010. The switch of intestinal Slc26 exchangers from anion absorptive to HCO3-secretory mode is dependent on CFTR anion channel function. Am. J. Physiol. Cell Physiol. 298:C1057-65
81. Walker NM, Simpson JE, Brazill JM, Gill RK, Dudeja PK, et al. 2009. Role of down-regulated in adenoma anion exchanger in HCO3-secretion across murine duodenum. Gastroenterology 136:893-901.e2
82. Walker NM, Simpson JE, Yen PF, Gill RK, Rigsby EV, et al. 2008. Down-regulated in adenoma Cl/HCO3 exchanger couples with Na/H exchanger 3 for NaCl absorption in murine small intestine. Gastroenterology 135:1645-1653.e3
83. Turnberg LA, Bieberdorf FA, Morawski SG, Fordtran JS. 1970. Interrelationships of chloride, bicarbonate, sodium, and hydrogen transport in the human ileum. J. Clin. Investig. 49:557-67
84. Turnberg LA, Fordtran JS, Carter NW, Rector FC Jr. 1970. Mechanism of bicarbonate absorption and its relationship to sodium transport in the human jejunum. J. Clin. Investig. 49:548-56
85. Turnberg LA, Bieberdorf FA, Fordtran JS. 1969. Electrolyte transport in the human ileum. Gut 10:1044
86. Dekkers JF,Wiegerinck CL, Jonge HR, Bronsveld I, Janssens HM, et al. 2013. A functional CFTR assay using primary cystic fibrosis intestinal organoids. Nat. Med. 19:939-45
87. Dekkers JF, Gogorza Gondra RA, Kruisselbrink E, Vonk AM, Janssens HM, et al. 2016. Optimal correction of distinct CFTR folding mutants in rectal cystic fibrosis organoids. Eur. Respirat. J. In press. doi: 10.1183/13993003.01192-2015
88. Vidović D, CarlonMS, Cunha MF,Dekkers JF,HollenhorstMI, et al. 2015. rAAV-CFTR R rescues the cystic fibrosis phenotype in human intestinal organoids and cystic fibrosis mice. Am. J. Respir. Crit. Care Med. 193:288-98
89. Drost J, van Jaarsveld RH, Ponsioen B, Zimberlin C, van Boxtel R, et al. 2015. Sequential cancer mutations in cultured human intestinal stem cells. Nature 521:43-47
90. VanDussenKL, Marinshaw JM, ShaikhN,Miyoshi H, Moon C, et al. 2015. Development of an enhanced human gastrointestinal epithelial culture system to facilitate patient-based assays. Gut 64:911-20
91. Yin Y, Bijvelds M, Dang W, Xu L, van der Eijk AA, et al. 2015. Modeling rotavirus infection and antiviral therapy using primary intestinal organoids. Antivir. Res. 123:120-31
92. Saxena K, Blutt SE, Ettayebi K, Zeng XL, Broughman JR, et al. 2016. Human intestinal enteroids: a new model to study human rotavirus infection, host restriction, and pathophysiology. J. Virol. 90:43-56
93. Finkbeiner SR, Zeng XL, Utama B, Atmar RL, Shroyer NF, Estes MK. 2012. Stem cell-derived human intestinal organoids as an infection model for rotaviruses. mBio 3:00159-12
94. Lundgren O, Peregrin AT, Persson K, Kordasti S, Uhnoo I, Svensson L. 2000. Role of the enteric nervous system in the fluid and electrolyte secretion of rotavirus diarrhea. Science 287:491-95
95. Zachos NC, Foulke-Abel J, Biswas RS, In J, Wang P, et al. 2014. Rotavirus inhibits NHE3 activity via clathrin-independent endocytosis resulting in increased NHE3 degradation. Gastroenterology 146(Suppl. 1):696-97
96. Kuehne SA, Cartman ST, Heap JT, Kelly ML, Cockayne A,Minton NP. 2010. The role of toxin A and toxin B in Clostridium difficile infection. Nature 467:711-13
97. Dillon ST, Rubin EJ, Yakubovich M, Pothoulakis C, LaMont JT, et al. 1995. Involvement of Ras-related Rho proteins in the mechanisms of action of Clostridium difficile toxin A and toxin B. Infect. Immun. 63:1421-26
98. Leslie JL, Huang S, Opp JS, Nagy MS, Kobayashi M, et al. 2015. Persistence and toxin production by Clostridium difficile within human intestinal organoids result in disruption of epithelial paracellular barrier function. Infect. Immun. 83:138-45
99. Engevik MA, Engevik KA, Yacyshyn MB, Wang J, Hassett DJ, et al. 2015. Human Clostridium difficile infection: inhibition ofNHE3and microbiota profile.Am. J. Physiol.Gastrointest.LiverPhysiol. 308:G497-509
100. Hayashi H, Szaszi K, Coady-Osberg N, FuruyaW, Bretscher AP, et al. 2004. Inhibition and redistribution of NHE3, the apical Na+/H+ exchanger, by Clostridium difficile toxin B. J. Gen. Physiol. 123:491-504
101. Steele J, Parry N, Tzipori S. 2014. The roles of toxin A and toxin B in Clostridium difficile infection. Gut Microbes 5:53-7
102. Lyras D, O'Connor JR, Howarth PM, Sambol SP, Carter GP, et al. 2009. Toxin B is essential for virulence of Clostridium difficile. Nature 458:1176-79
103. Chen S, Sun C, Wang H, Wang J. 2015. The Role of Rho GTPases in Toxicity of Clostridium difficile Toxins. Toxins 7:5254-67
104. Mather AE, Reid SWJ, Maskell DJ, Parkhill J, Fookes MC, et al. 2013. Distinguishable epidemics of multidrug-resistant Salmonella Typhimurium dt104 in different hosts. Science 341:1514-17
105. Forbester JL, Goulding D, Vallier L, Hannan N, Hale C, et al. 2015. Interaction of Salmonella enterica Serovar Typhimurium with intestinal organoids derived from human induced pluripotent stem cells. Infect. Immun. 83:2926-34
106. Law RJ, Gur-Arie L, Rosenshine I, Finlay BB. 2013. In vitro and in vivo model systems for studying enteropathogenic Escherichia coli infections. Cold Spring Harb. Perspect. Med. 3:a009977
107. Mohawk KL, O'Brien AD. 2011. Mouse models of Escherichia coli O157:H7 infection and shiga toxin injection. J. Biomed. Biotechnol. 2011:25818
108. Ermund A, Schutte A, Johansson ME, Gustafsson JK, Hansson GC. 2013. Studies of mucus in mouse stomach, small intestine, and colon. I. Gastrointestinal mucus layers have different properties depending on location as well as over the Peyer's patches. Am. J. Physiol. Gastrointest. Liver Physiol. 305:G341-47
109. JohanssonME, Sj övall H, Hansson GC. 2013. The gastrointestinal mucus system in health and disease. Nat. Rev. Gastroenterol. Hepatol. 10:352-61
110. Erdem AL, Avelino F, Xicohtencatl-Cortes J, Girón JA. 2007. Host protein binding and adhesive properties of H6 and H7 flagella of attaching and effacing Escherichia coli. J. Bacteriol. 189:7426-35
111. Wang J, Cortina G,Wu SV, Tran R, Cho J-H, et al. 2006. Mutant Neurogenin-3 in congenital malabsorptive diarrhea. N. Engl. J. Med. 355:270-80
112. Overeem AW, Posovszky C, Rings EHMM, Giepmans BNG, Ijzendoorn SCD. 2016. The role of enterocyte defects in the pathogenesis of congenital diarrheal disorders. Dis. Models Mech. 9:1-12
113. Müller T, Rasool I, Heinz-Erian P, Mildenberger E, Hülstrunk C, et al. 2016. Congenital secretory diarrhoea caused by activating germline mutations in GUCY2C. Gut 65:1306-13
114. Canani RB, Castaldo G, Bacchetta R, Martin MG, Goulet O. 2015. Congenital diarrhoeal disorders: advances in this evolving web of inherited enteropathies. Nat. Rev. Gastroenterol. Hepatol. 12:293-302
115. Janecke AR, Heinz-Erian P, Yin J, Petersen BS, Franke A, et al. 2015. Reduced sodium/proton exchanger NHE3 activity causes congenital sodium diarrhea. Hum. Mol. Genet. 24:6614-23
116. Schneeberger K, Vogel GF, Teunissen H, van Ommen DD, Begthel H, et al. 2015. An inducible mouse model for microvillus inclusion disease reveals a role for myosin Vb in apical and basolateral trafficking. PNAS 112:12408-13
117. Weis GV, Knowles BC, Choi E, Goldstein AE, Williams JA, et al. 2016. Loss of MYO5B in mice recapitulates microvillus inclusion disease and reveals an apical trafficking pathway distinct to neonatal duodenum. Cell. Mol. Gastroenterol. Hepatol. 2:131-57
118. Wiegerinck CL, Janecke AR, Schneeberger K, Vogel GF, Haaften-Visser DY, et al. 2014. Loss of syntaxin 3 causes variant microvillus inclusion disease. Gastroenterology 147:65-68.e10
119. AgarwalNS, Northrop L, Anyane-Yeboa K, AggarwalVS, Nagy PL,Demirdag YY. 2014. Tetratricopeptide repeat domain 7A (TTC7A) mutation in a newborn with multiple intestinal atresia and combined immunodeficiency. J. Clin. Immunol. 34:607-10
120. Avitzur Y, Guo C, Mastropaolo LA, Bahrami E, Chen H, et al. 2014. Mutations in Tetratricopeptide repeat domain 7A result in a severe form of very early onset inflammatory bowel disease. Gastroenterology 146:1028-39
121. Lemoine R, Pachlopnik-Schmid J, Farin HF, Bigorgne A, Debré M, et al. 2014. Immune deficiency-related enteropathy-lymphocytopenia-alopecia syndrome results from tetratricopeptide repeat domain 7A deficiency. J. Allergy Clin. Immunol. 134:1354-1364.e6
122. Bigorgne AE, Farin HF, Lemoine R, Mahlaoui N, Lambert N, et al. 2014. TTC7A mutations disrupt intestinal epithelial apicobasal polarity. J. Clin. Investig. 124:328-37
123. Hartley JL, Zachos NC, Dawood B, Donowitz M, Forman J, et al. 2010. Mutations in TTC37 cause trichohepatoenteric syndrome (phenotypic diarrhea of infancy). Gastroenterology 138:2388-98. e1-2
124. Schwank G, Koo BK, Sasselli V, Dekkers JF, Heo I, et al. 2013. Functional repair of CFTR by CRISPR/Cas9 in intestinal stem cell organoids of cystic fibrosis patients. Cell Stem Cell 13:653-58
125. Vogelstein B, Papadopoulos N, Velculescu VE, Zhou S, Diaz LA Jr., Kinzler KW. 2013. Cancer genome landscapes. Science 339:1546-58
126. Garraway LA, Lander ES. 2013. Lessons from the cancer genome. Cell 153:17-37
127. Fearon ER, Vogelstein B. 1990. A genetic model for colorectal tumorigenesis. Cell 61:759-67
128. Fearon ER. 2011. Molecular genetics of colorectal cancer. Annu. Rev. Pathol. 6:479-507
129. van Wetering M, Francies HE, Francis JM, Bounova G, Iorio F, et al. 2015. Prospective derivation of a living organoid biobank of colorectal cancer patients. Cell 161:933-45
130. Madan B, Ke Z,Harmston N, Ho SY, Frois AO, et al. 2016. Wnt addiction of genetically defined cancers reversed by PORCN inhibition. Oncogene 35:2197-207
131. Yui S, Nakamura T, Sato T, Nemoto Y, Mizutani T, et al. 2012. Functional engraftment of colon epithelium expanded in vitro from a single adult Lgr5+ stem cell. Nat. Med. 18:618-23
132. Fattahi F, Steinbeck JA, Kriks S, Tchieu J, Zimmer B, et al. 2016. Deriving human ENS lineages for cell therapy and drug discovery in Hirschsprung disease. Nature 531:105-9
133. Wieck MM, El-Nachef WN, Hou X, Spurrier RG, Holoyda KA, et al. 2016. Human and murine tissueengineered colon exhibit diverse neuronal subtypes and can be populated by enteric nervous system progenitor cells when donor colon is aganglionic. Tissue Eng. A 22:53-64
134. Mahe MM, Workman M, Poling H,Watson CL, Sundaram N, et al. 2016. Functional enteric nervous system in human small intestine derived from pluripotent stem cells. Gastroenterology 150:A144-45
135. Woodcock J,Woosley R. 2008. The FDA critical path initiative and its influence on new drug development. Annu. Rev. Med. 59:1-12
136. Rogoz A, Reis BS, Karssemeijer RA, Mucida D. 2015. A 3-D enteroid-based model to study T-cell and epithelial cell interaction. J. Immunol. Methods 421:89-95
137. Fiskerstrand T, Arshad N, Haukanes BI,Tronstad RR, Pham KD, et al. 2012. Familial diarrhea syndrome caused by an activating GUCY2C mutation. N. Engl. J. Med. 366:1586-95